Evaluate Companies

 
News Articles for Evaluate Companies top ^
2013/1/29
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0849853001&sourceType=1 http://www.ccnmatthews.com/logos/20090904-tgl_logo.jpg CALGARY, ALBERTA --
Sign-up for TransGlobe Energy Corporation Announces 2012 Year-End Contingent Resources and Propsective Resource Evaluation investment picks
2013/5/13
Cequence Energy announces first quarter financial results, updated independent reserves evaluation and independent resource evaluation Canada NewsWire Financial and Operating           2013 2012 %  Change Financial ($)               Production revenue (1)         22,005 19,864                11 Comprehensive loss         (5,439) (7,936) (31) Per share, basic and diluted         (0.03) (0.05) (40) Funds flow from operations (2)         10,652 6,755 58 Per share, basic and diluted         0.05 0.04 25 Production volumes  
Sign-up for Cequence Energy announces first quarter financial results, updated independent reserves evaluation and independent resource evaluation investment picks
2013/3/22
The first paragraph has been replaced.
Sign-up for CORRECTING and REPLACING FDA Approves GE Healthcare's AdreView™ (Iobenguane I 123 Injection) for Cardiac Risk Evaluation in Heart Failure Patients investment picks
2013/3/13
Kit includes everything needed to fully evaluate high-speed data converters DALLAS , March 13, 2013 /PRNewswire/ -- Texas Instruments Incorporated (TI) (NASDAQ: TXN) introduced the industry's first complete high-speed data converter system evaluation kit (HSDC-SEK), which significantly reduces system evaluation costs and enables designers to get their system running in minutes.
Sign-up for TI introduces industry's first complete high-speed data converter system evaluation kit investment picks
2013/5/1
OncoGenex Announces Plans for the Initiation of the Rainier™ Clinical Trial Evaluating OGX-427 in Combination with ABRAXANE® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer Canada NewsWire Pancreatic Cancer Becomes the Fourth Tumor Type Evaluated as Part of the OGX-427 ORCA™ Program, In Addition to Bladder, Lung and Prostate Cancers BOTHELL, Wash.
Sign-up for OncoGenex Announces Plans for the Initiation of the Rainier™ Clinical Trial Evaluating OGX-427 in Combination with ABRAXANE® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer investment picks
2013/2/26
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0856153001&sourceType=1 http://www.ccnmatthews.com/logos/20100104-argosy.jpg CALGARY, ALBERTA --
Sign-up for Argosy Energy Inc. Announces Amendments to Its Credit Facility and Provides Results of Its December 31, 2012 Reserve Evaluation investment picks
2013/5/1
Pancreatic Cancer Becomes the Fourth Tumor Type Evaluated as Part of the OGX-427 ORCA™ Program, In Addition to Bladder, Lung and Prostate Cancers BOTHELL, Wash.
Sign-up for OncoGenex Announces Plans for the Initiation of the Rainier™ Clinical Trial Evaluating OGX-427 in Combination with ABRAXANE® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer investment picks
2013/5/14
MEDFORD, N.Y., May 14, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI) , a leader in point-of-care diagnostic tests for infectious diseases, announces receipt of an evaluation report from Mexico's Institute of Epidemiological Diagnosis and Reference (InDRE) regarding the Company's DPP ® HIV-Syphilis multiplex test, which showed the Company's assay performed with 100% agreement for both markers on all 941 samples tested.
Sign-up for Chembio's DPP(R) HIV-Syphilis Multiplex Test Demonstrates 100% Sensitivity and Specificity in Evaluation by Mexico's Institute of Epidemiological Diagnosis and Reference investment picks
2013/3/7
International Rectifier, IR ® (NYSE: IRF) , a world leader in power management technology, today announced the enhancement of its Insulated Gate Bipolar Transistor (IGBT) selection tool that enables design optimization in a wide range of applications including motor drives, uninterruptable power supplies (UPS), solar inverters, and welding.
Sign-up for IR Enhances Online IGBT Product Selector and Performance Evaluator Tool to Further Simplify Device Selection and Optimization investment picks
2013/3/6
The Special Committee of Dell’s Board of Directors today issued the following statement regarding its evaluation of Dell’s (NASDAQ:DELL) strategic alternatives: “The Special Committee, consisting solely of independent directors and working with our independent legal and financial advisors, undertook a rigorous process, over a period of more than five months, to evaluate Dell’s current risks, opportunities and strategic alternatives.
Sign-up for Dell Special Committee Issues Statement Regarding Its Evaluation of Strategic Alternatives investment picks
2013/2/12
OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer Canada NewsWire Company Reaffirms Commitment to Addressing Treatment Resistance in Genitourinary (GU) Cancers with Fourth Phase 2 GU trial in OGX-427 ORCA Program BOTHELL, Wash.
Sign-up for OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer investment picks
2013/3/13
Pacific Rubiales Announces Arbitration Decision Regarding High-Price Provisions in its Quifa Association Contract and Evaluates Next Course of Action Canada NewsWire TORONTO , March 13, 2013 /CNW/ - Pacific Rubiales Energy Corp.
Sign-up for Pacific Rubiales Announces Arbitration Decision Regarding High-Price Provisions in its Quifa Association Contract and Evaluates Next Course of Action investment picks
2013/4/4
pSivida Corp.
Sign-up for pSivida Announces Tech Evaluation Agreement With Leading Global Pharmaceutical Company investment picks
2013/4/11
OncoGenex Announces Plans for the Initiation of the Spruce™ Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer Canada NewsWire Company Expands Development Program with Fifth Phase 2 Clinical Trial in the OGX-427 ORCA™ Program BOTHELL, Wash.
Sign-up for OncoGenex Announces Plans for the Initiation of the Spruce™ Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer investment picks
2013/3/8
An evaluation by Mitsubishi Heavy Industries (MHI) made public today cites ineffective tube supports, dry steam and high steam flow velocity as causes of excessive wear in the steam generators MHI supplied to Southern California Edison’s (SCE) San Onofre Nuclear Generating Station.
Sign-up for Southern California Edison Comments on MHI Evaluation of San Onofre Nuclear Plant Steam Generators investment picks
2013/3/8
St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, today announced the first patient implant in a new pivotal trial evaluating the company’s AMPLATZER ™ Cardiac Plug (ACP) for the prevention of stroke.
Sign-up for St. Jude Medical Announces First Implant in Pivotal Phase of Clinical Trial Evaluating AMPLATZER Cardiac Plug for the Prevention of Stroke in Patients with Atrial Fibrillation investment picks
2013/1/30
Wireline evaluation program confirms oil discovery in the Kangaroo-1 exploration well, Karoon blocks, offshore Santos Basin, Brazil Canada NewsWire Cautionary Note Concerning Forward-Looking Statements This news release contains forward-looking statements.
Sign-up for Wireline evaluation program confirms oil discovery in the Kangaroo-1 exploration well, Karoon blocks, offshore Santos Basin, Brazil investment picks
2013/3/20
CLEARWATER, Fla., March 20, 2013 (GLOBE NEWSWIRE) -- Nicholas Financial, Inc. (Nasdaq:NICK) announced today that the Board of Directors of the Company has retained Janney Montgomery Scott LLC as its independent financial advisor to assist the Board of Directors in evaluating possible strategic alternatives for the Company, including, but not limited to, the possible sale of the Company or certain of its assets, potential acquisition and expansion opportunities, and/or a possible debt or equity financing.
Sign-up for Nicholas Financial Retains Financial Advisor to Assist in Evaluating Strategic Alternatives investment picks
2013/4/2
PEORIA, AZ , April 2, 2013 /PRNewswire/ - Viking Minerals Inc. (VKML-OTCBB) announces on behalf of the Board of Directors that the Company has begun an evaluation process with a private Oil & Gas Company/Operator in the State of Texas .
Sign-up for Viking Minerals Inc: The Company evaluates a Joint-Venture project in an Oil field in Texas investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Evaluate Companies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: European Stocks  |  Next: Evaluating Strategic Alternatives